Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Endocrinol ; 416: 27-35, 2015 Nov 15.
Article in English | MEDLINE | ID: mdl-26284494

ABSTRACT

Human clinically non-functioning pituitary adenomas (NFAs) account for approximately 40% of diagnosed pituitary tumors. Epigenetic mutations in tumor suppressive genes play an important role in NFA development. Maternally expressed gene 3 (MEG3) is a long non-coding RNA (lncRNA) and we hypothesized that it is a candidate tumor suppressor whose epigenetic silencing is specifically linked to NFA development. In this study, we introduced MEG3 expression into PDFS cells, derived from a human NFA, using both inducible and constitutively active expression systems. MEG3 expression significantly suppressed xenograft tumor growth in vivo in nude mice. When induced in culture, MEG3 caused cell cycle arrest at the G1 phase. In addition, inactivation of p53 completely abolished tumor suppression by MEG3, indicating that MEG3 tumor suppression is mediated by p53. In conclusion, our data support the hypothesis that MEG3 is a lncRNA tumor suppressor in the pituitary and its inactivation contributes to NFA development.


Subject(s)
Genes, Tumor Suppressor , Pituitary Gland/metabolism , Pituitary Neoplasms/genetics , RNA, Long Noncoding/metabolism , Acetylation , Animals , Cell Cycle Checkpoints , Cell Line, Tumor , Epigenesis, Genetic , Female , G1 Phase , Heterografts , Humans , Mice , Mice, Nude , Primary Cell Culture , RNA, Long Noncoding/genetics , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...